2010 | Phase I/II Trial of GN-BVC, a Gemcitabine and Vinorelbine-Containing Conditioning Regimen for Autologous Hematopoietic Cell Transplantation in Recurrent and Refractory Hodgkin Lymphoma | Arai, S.; Letsinger, R.; Wong, R. M.; Johnston, L. J.; Laport, G. G.; Lowsky, R.; Miklos, D. B.; Shizuru, J. A.; Wen-Kai Weng ; Lavori, P. W.; Blume, K. G.; Negrin, R. S.; Horning, S. J. | Biology of Blood and Marrow Transplantation | | |
2009 | TLI and ATG conditioning with low risk of graft-versus-host disease retains antitumor reactions after allogeneic hematopoietic cell transplantation from related and unrelated donors | Kohrt, H. E.; Turnbull, B. B.; Heydari, K.; Shizuru, J. A.; Laport, G. G.; Miklos, D. B.; Johnston, L. J.; Arai, S.; Wen-Kai Weng ; Hoppe, R. T.; Lavori, P. W.; Blume, K. G.; Negrin, R. S.; Strober, S.; Lowsky, R. | Blood | | |